Compound ID | 87
Class: Celecoxib-derived antibacterial inhibitor
| Spectrum of activity: | Gram-negative |
| Details of activity: | Salmonella enterica serovar Typhimurium. Has also been shown to be an anti-mycobacterial agent (against Mycobacterium abscessus) |
| Propensity to select resistant mutants: | Yes |
| Institute where first reported: | Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan |
| Year first mentioned: | 2009 |
| Highest developmental phase: | Preclinical |
| Development status: | Active |
| Chemical structure(s): | |||||||||||
|
|